StockWatch
·

JENBURKT PHARMACEUTICALS LTD. Q2 FY26 Results

JENBURPHQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue45.5628.2%10.5%
Total Income47.6426.8%10.6%
Expenditure33.3021.5%9.0%
PBT14.3340.8%14.4%
Net Profit10.1630.4%5.9%
OPM28.76%3.55pp4.70pp
NPM21.34%0.61pp0.95pp
EPS23.0330.4%5.9%
View full financials

Informational and educational content only. Not investment advice.